Related references
Note: Only part of the references are listed.Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys
Heidi Tiller et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2012)
The maternal immune response to fetal platelet GPIbα causes frequent miscarriage in mice that can be prevented by intravenous IgG and anti-FcRn therapies
Conglei Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Molecular insight into human platelet antigens: structural and evolutionary conservation analyses offer new perspective to immunogenic disorders
Meytal Landau et al.
TRANSFUSION (2011)
Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review
M. M. Kamphuis et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2010)
Animal model of fetal and neonatal immune thrombocytopenia: role of neonatal Fc receptor in the pathogenesis and therapy
Pingguo Chen et al.
BLOOD (2010)
Transfusion of antibody-opsonized red blood cells results in a shift in the immune response from the red blood cell to the antibody in a murine model
Davor Brinc et al.
TRANSFUSION (2010)
Studies on the Mechanism by Which Antigen-Specific IgG Suppresses Primary Antibody Responses: Evidence for Epitope Masking and Decreased Localization of Antigen in the Spleen
A. Getahun et al.
SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2009)
Blockade of maternal anti-HPA-1a-mediated platelet clearance by an HPA-1a epitope-specific F(ab')2 in an in vivo mouse model of alloimmune thrombocytopenia
Tamam Bakchoul et al.
TRANSFUSION (2009)
Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn
D. Brinc et al.
Hematology-American Society of Hematology Education Program (2009)
Lessons learnt from many years of experience using anti-D in humans for prevention of RhD immunization and haemolytic disease of the fetus and newborn
B. M. Kumpel
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
A prospective study of maternal anti-HPA 1a antibody level as a potential predictor of alloimmune thrombocytopenia in the newborn
Mette Kjaer Killie et al.
HAEMATOLOGICA (2008)
Efficacy of RhD monoclonal antibodies in clinical trials as replacement therapy for prophylactic anti-D immunoglobulin: More questions than answers
B. M. Kumpel
VOX SANGUINIS (2007)
A screening and intervention program aimed to reduce mortality and serious morbidity associated with severe neonatal alloimmune thrombocytopenia
Jens Kjeldsen-Kragh et al.
BLOOD (2007)
Management and outcome of 200 cases of fetomaternal alloimmune thrombocytopenia
Cedric Ghevaert et al.
TRANSFUSION (2007)
A novel murine model of fetal and neonatal alloimmune thrombocytopenia: response to intravenous IgG therapy
HY Ni et al.
BLOOD (2006)
Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a
ML Turner et al.
TRANSFUSION (2005)
Evaluation of a new flow cytometric HPA 1a screening method - A rapid and reliable tool for HPA 1a screening of blood donors and pregnant women
MK Killie et al.
TRANSFUSION AND APHERESIS SCIENCE (2004)
The natural history of maternal immunization against foetal platelet alloantigens
H Ohto et al.
TRANSFUSION MEDICINE (2004)
Will it ever be possible to balance the risk of intracranial haemorrhage in fetal or neonatal alloimmune thrombocytopenia against the risk of treatment strategies to prevent it?
CM Radder et al.
VOX SANGUINIS (2003)
Feto-maternal alloimmune thrombocytopenia: a literature review and statistical analysis
JA Spencer et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2001)
Maternal anti-D prophylaxis during pregnancy does not cause neonatal haemolysis
A Maayan-Metzger et al.
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2001)
The management of alloimmune neonatal thrombocytopenia
VS Blanchette et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2000)
Monoclonal antibody-mediated inhibition of the human HLA alloimmune response to platelet transfusion is antigen specific and independent of Fcγ receptor-mediated immune suppression
AR Crow et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
